MedPath

Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity

Not Applicable
Conditions
Obesity
Interventions
Device: ANíMATE mobile application
Registration Number
NCT05236881
Lead Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Brief Summary

This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity.

The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring.

Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Patients over 18 years of age.
  • People with BMI 30-39.9 kg/m2.
  • Have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and have sufficient capabilities to use it.
  • Have access to a scale for regular weight monitoring.
Exclusion Criteria
  • Presence of serious major comorbidities: High blood pressure treated with > 3 drugs, diabetes mellitus treated with insulin, dyslipidemia treated with PCSK9 inhibitors, sleep apnea-hypopnea syndrome treated with CPAP, ischemic heart disease or stroke.
  • Use of pharmacological treatment with influence on weight started in the 6 months prior to study entry.
  • History of weight loss intervention (diet, exercise) in the 6 months prior to study entry.
  • History of eating disorder.
  • History of bariatric surgery.
  • Use of any other app or treatment to lose weight in the 6 months prior to study entry.
  • Pregnancy, short-term gestational desire or lactation.
  • Any other disease or condition that may interfere with compliance with the protocol or completion of the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ANíMATE mobile applicationANíMATE mobile applicationStandard care protocol (3 face-to-face visits: basal, 2 and 4 months) + ANíMATE mobile application
Primary Outcome Measures
NameTimeMethod
%TWL at 4 months4 months

Percentage of total weight loss (%TWL) at 4 months

Secondary Outcome Measures
NameTimeMethod
Blood pressure change at 2 and 4 monthsBaseline, 2 and 4 months

Change in systolic and diastolic blood pressure (mmhg) from baseline to 2 and 4 months

%TWL at 2 months2 months

Percentage of total weight loss (%TWL) at 2 months

%EWL at 2 and 4 months2 and 4 months

Percentage of excess weight loss (%EWL) at 2 and 4 months

BMI change at 2 and 4 monthsBaseline, 2 and 4 months

Change in body mass index (BMI) (kg/m\^2) from baseline to 2 and 4 months

Waist change at 2 and 4 monthsBaseline, 2 and 4 months

Change in waist circumference (cm) from baseline to 2 and 4 months

HbA1c change at 2 and 4 monthsBaseline, 2 and 4 months

Change in HbA1c percent from baseline to 2 and 4 months

Mediterranean diet adherence change at 4 monthsBaseline and 4 months

Change in mediterranean diet adherence questionnaire score (0\*-14, \*indicates worse questionnaire results) from baseline to 4 months

IPAQ change at 4 monthsBaseline and 4 months

Change in International Physical Activity Questionnaire (IPAQ) score (cathegory results: low/inactive\*, moderate or high, \*indicates worse questionnaire results) from baseline to 4 months

ACTA change at 4 monthsBaseline and 4 months

Change in attitudes towards change in eating disorders (ACTA) questionnaire score (0\*-236, \*indicates worse questionnaire results) from baseline to 4 months

Adherence to records2 and 4 months

Percentage of records (weight, diet) at 2 and 4 months

Adherence to recommendations2 and 4 months

Percentage of recommendations given by the medical team followed at next visit

Adherence to visits2 and 4 months

Percentage of face-to-face visits attended

Adherence to the app2 months after the end of the study

Percentage of patients who continue using the 2 months app after the end of the study

Quality of life change at 4 monthsBaseline and 4 months

Change in Short-Form Health Survey SF-36 questionnaire score (0\*-100, \*indicates worse questionnaire results) from baseline to 4 months

Satisfaction with the app4 months

Satisfaction questionnaire in relation to the use of the app score (0\*-20, \*indicates worse questionnaire results) in the intervention group at the end of the study

Trial Locations

Locations (1)

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath